Navigation Links
Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk
Date:10/17/2007

ime at the Events Center at St. Mary's Cathedral, 1111 Gough St., San Francisco. The fair is sponsored by American Bone Health, in partnership with FORE and the University of California, San Francisco. In addition to the free bone density scanning, Kyphon representatives will be at the fair offering height measurement because loss of height can be an early indication of spinal fractures caused by osteoporosis. For more information about the event, contact FORE at 888-266-3015.

Kyphon is also supporting local and national awareness campaigns of osteoporosis organizations around the globe such as the Irish Osteoporosis Society (IOS), the Fundacion Hispana de Osteoporosis y Enfermedades Metabolicas (FHOEMO) of Spain, and the Italian Association for Patients with Osteoporosis (AECOS). In addition, Kyphon is offering free osteoporosis patient education posters for physicians' offices in countries across Europe.

Osteoporosis, a term that means "porous bones," is a disease in which bones become weak and can easily break. It is known as "the silent disease" because many of the estimated 75 million women and men in the United States, Europe and Japan who suffer from osteoporosis do not know they are losing bone mass until they experience a spine, hip or wrist fracture. Of the 1.5 million fractures attributable to osteoporosis that occur annually in the U.S., nearly half are spinal fractures, according to the National Osteoporosis Foundation. Kyphon markets medical devices that are used in minimally invasive therapies for the treatment of spinal fractures in order to improve the quality of life of those affected by spinal fractures caused by osteoporosis and cancer.

About Kyphon Inc.

Kyphon develops and markets medical devices designed to restore and preserve spinal function and diagnose the source of low back pain using minimally invasive technologies. The company's products are used in balloon kyphoplasty for the treatment of spinal compression fract
'/>"/>

SOURCE Kyphon Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Vitamin E supports Female Hearts
2. Injection supports Heart Devices
3. Study supports vegetable diet
4. Study supports century-old cancer theory
5. Google Supports Indians Novel Literacy Drive
6. Actor Anil Kapoor Supports Birth Registration Cause
7. AMA Supports Tax Penalty for Uninsured Americans
8. Church Supports HIV Test Before Marriage
9. EHRVA Supports EHR Product Certification
10. NICE supports application of advanced biological therapies as treatment option for acute psoriasis
11. Bush Supports Restriction to ‘Morning–After’ Pll
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... A US Airman, fresh from basic training...leukemia patient whose life he saved by donating h...san Air Base, Republic of Korea (PRWEB) November 2...Airman whose blood donation saved her life, met fo...Nov. 21, 2008. , , , , ,Airman Tamarias Pope, 8th...
(Date:11/21/2008)...g of shareholders to be held on January 8, 2009 ,... Med-Emerg International Inc. ("MedEmerg") (OTCBB:...h services, announced today that it has obtained a... Justice concerning its previously announced plan ...ch AIM Health Group Inc. ("AIM") will acquire all ...
(Date:11/21/2008)...., Nov. 21 Heska Corpora...esent at the New York Society of,Security Analyst...ence on,December 2, 2008 at 1177 Avenue of the Am...on is scheduled to begin at 9:35 a.m. Eastern Time...via live webcast and for two weeks,following the ...
(Date:11/21/2008)...Banzel proved effective against Lennox-Gastaut syn...s) -- A new drug called Banzel (rufinamide) has be...ere form of epilepsy called Lennox-Gastaut syndrom... Friday. , The approval was based on results of...s ages 4 to 30. Compared to patients who took a pl...
Breaking Medicine News(10 mins):Health News:Life-Saving Airman, Leukemia Patient Meet for First Time 2Health News:Life-Saving Airman, Leukemia Patient Meet for First Time 3Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:FDA Approves New Drug for Severe Epilepsy 2
...study shows a clear link between fast food consump...sting that // fast food increases the risk of obes...the association between reported fast food habits ...insulin resistance over 15 years. The diets of mor...
...nk between migraines and the risk of coronary hear...t study shows // no link between the two but does ...est pain, also known as angina. People with a hist... aura -- seeing what appears to be spots or lines ...
...t form of macular degeneration represents about 10...lated macular degeneration is the leading cause of...rs of age and older. // Two new studies show a the...n effective treatment for age-related, "wet" macul...
..., more intense physical activity can help maintain...rchers according to // a new study. For the study ...1900 and 1920 from the Finland, Italy, and Netherl...ty of physical activities of the participants was ...
Other Medicine News:
(Date:11/20/2008).... 20 PAREXEL Internation... biopharmaceutical services provider, today announ...provide regulatory consulting and clinical researc...ce, PAREXEL now has locations throughout five impo...which also include Argentina, Brazil, Chile, and M...
(Date:11/19/2008)...ientists report basic findings on critical enzyme,...better treat an array of disorders , , MEMP...ientists at St. Jude Children,s Research Hospital ... the body,s enzyme workhorses called calpains. ,...lpains function in many cellular processes, includ...
(Date:11/18/2008)...christmasseals.org to learn more, make a donation...NGTON, Nov. 17 Millions...th, courtesy of the American Lung Association. The... fundraising tradition dating back to 1907 when th...osis. , , "Most Americans alive today hav...
(Date:11/13/2008)..., Mass., Nov. 13 Hologic...facturer and supplier of premium,diagnostics, medi...d to,serving the healthcare needs of women, today ...k pivotal clinical trial. The Cervista HPV high-ri...e U.S. and is expected to be,launched in the Europ...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4PhoneTree Announces New Patient Messaging Product and Pricing Options 4660 1Roper Industries Announces Record Third Quarter Results 4657 1Roper Industries Announces Record Third Quarter Results 4657 2Roper Industries Announces Record Third Quarter Results 4657 3Roper Industries Announces Record Third Quarter Results 4657 4Roper Industries Announces Record Third Quarter Results 4657 5Roper Industries Announces Record Third Quarter Results 4657 6Roper Industries Announces Record Third Quarter Results 4657 7Roper Industries Announces Record Third Quarter Results 4657 8Roper Industries Announces Record Third Quarter Results 4657 9Roper Industries Announces Record Third Quarter Results 4657 10Male Drivers are Hitting Killing Most Child Pedestrians New Study Shows 4654 1Male Drivers are Hitting Killing Most Child Pedestrians New Study Shows 4654 2Male Drivers are Hitting Killing Most Child Pedestrians New Study Shows 4654 3California Association of Marriage 26 Family Therapists Offers Tips on How to Cope With a Traumatic Event 4651 1California Association of Marriage 26 Family Therapists Offers Tips on How to Cope With a Traumatic Event 4651 2
... at International Conference on Antiviral,Research...- ADVENTRX,Pharmaceuticals, Inc. , a biopharmaceut...ommercializing proprietary product,candidates for ...nnounced today that it presented results demonstra...influenza (bird flu) viruses when,the Company,s br...
...Plus Minocycline Showed Substantial,Reduction of D...Remitting Multiple Sclerosis , Combination Treatme...nd Was Well Tolerated , KANSAS CITY, Mo, May 4, 20...y showed that a combination of Copaxone,(glatirame...c,minocycline reduced T1 Gadolinium (Gd)-enhancing...
Other Medicine Technology:ANX-201 Drug Combination Demonstrates Synergistic Activity Against,Human and Bird Flu Viruses 2ANX-201 Drug Combination Demonstrates Synergistic Activity Against,Human and Bird Flu Viruses 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 6Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 7Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 8Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 9Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 10Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 11Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 12
Needle holder, delicate, curved without lock
Rhoton microscopic forceps, straight
Microscopic scissors, curved
Our unique velcro design apron with elasticized back panels for additional support and comfort. Shoulder pads are a standard. Shoulder drop-away optional.
Medicine Products: